↓ Skip to main content

Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Overview of attention for article published in PharmacoEconomics, November 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy
1 policy source
twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
46 Mendeley
Title
Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Published in
PharmacoEconomics, November 2018
DOI 10.1007/s40273-018-0738-y
Pubmed ID
Authors

Bram L. T. Ramaekers, Rob Riemsma, Sabine Grimm, Debra Fayter, Sohan Deshpande, Nigel Armstrong, Willem Witlox, Xavier Pouwels, Steven Duffy, Gill Worthy, Jos Kleijnen, Manuela A. Joore

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 17%
Researcher 6 13%
Student > Postgraduate 5 11%
Other 4 9%
Student > Bachelor 4 9%
Other 4 9%
Unknown 15 33%
Readers by discipline Count As %
Medicine and Dentistry 17 37%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Chemistry 3 7%
Biochemistry, Genetics and Molecular Biology 2 4%
Psychology 2 4%
Other 4 9%
Unknown 14 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2020.
All research outputs
#6,230,656
of 23,924,386 outputs
Outputs from PharmacoEconomics
#741
of 1,926 outputs
Outputs of similar age
#107,566
of 346,954 outputs
Outputs of similar age from PharmacoEconomics
#13
of 37 outputs
Altmetric has tracked 23,924,386 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 1,926 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,954 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.